195 related articles for article (PubMed ID: 33300671)
1. A Functional Chemiluminescent Probe for in Vivo Imaging of Natural Killer Cell Activity Against Tumours.
Scott JI; Gutkin S; Green O; Thompson EJ; Kitamura T; Shabat D; Vendrell M
Angew Chem Int Ed Engl; 2021 Mar; 60(11):5699-5703. PubMed ID: 33300671
[TBL] [Abstract][Full Text] [Related]
2. A Functional Chemiluminescent Probe for in Vivo Imaging of Natural Killer Cell Activity Against Tumours.
Scott JI; Gutkin S; Green O; Thompson EJ; Kitamura T; Shabat D; Vendrell M
Angew Chem Weinheim Bergstr Ger; 2021 Mar; 133(11):5763-5767. PubMed ID: 38505495
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes.
Janiszewski T; Kołt S; Kaiserman D; Snipas SJ; Li S; Kulbacka J; Saczko J; Bovenschen N; Salvesen G; Drąg M; Bird PI; Kasperkiewicz P
J Biol Chem; 2020 Jul; 295(28):9567-9582. PubMed ID: 32439802
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.
Baginska J; Viry E; Berchem G; Poli A; Noman MZ; van Moer K; Medves S; Zimmer J; Oudin A; Niclou SP; Bleackley RC; Goping IS; Chouaib S; Janji B
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17450-5. PubMed ID: 24101526
[TBL] [Abstract][Full Text] [Related]
5. Chemiluminescent Probe for the In Vitro and In Vivo Imaging of Cancers Over-Expressing NQO1.
Son S; Won M; Green O; Hananya N; Sharma A; Jeon Y; Kwak JH; Sessler JL; Shabat D; Kim JS
Angew Chem Int Ed Engl; 2019 Feb; 58(6):1739-1743. PubMed ID: 30561862
[TBL] [Abstract][Full Text] [Related]
6. Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.
Scott GB; Bowles PA; Wilson EB; Meade JL; Low BC; Davison A; Blair GE; Cook GP
Biochem J; 2010 Nov; 431(3):423-31. PubMed ID: 20704564
[TBL] [Abstract][Full Text] [Related]
7. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period.
Niavarani SR; Lawson C; Bakos O; Boudaud M; Batenchuk C; Rouleau S; Tai LH
BMC Cancer; 2019 Aug; 19(1):823. PubMed ID: 31429730
[TBL] [Abstract][Full Text] [Related]
8. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
[TBL] [Abstract][Full Text] [Related]
9. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
[TBL] [Abstract][Full Text] [Related]
10. EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.
Oberoi P; Jabulowsky RA; Bähr-Mahmud H; Wels WS
PLoS One; 2013; 8(4):e61267. PubMed ID: 23573299
[TBL] [Abstract][Full Text] [Related]
11. Single-Fluorescent Protein Reporters Allow Parallel Quantification of Natural Killer Cell-Mediated Granzyme and Caspase Activities in Single Target Cells.
Liesche C; Sauer P; Prager I; Urlaub D; Claus M; Eils R; Beaudouin J; Watzl C
Front Immunol; 2018; 9():1840. PubMed ID: 30135688
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.
Friedman J; Morisada M; Sun L; Moore EC; Padget M; Hodge JW; Schlom J; Gameiro SR; Allen CT
J Immunother Cancer; 2018 Jun; 6(1):59. PubMed ID: 29925431
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells kill extracellular Pseudomonas aeruginosa using contact-dependent release of granzymes B and H.
Feehan DD; Jamil K; Polyak MJ; Ogbomo H; Hasell M; Li SS; Xiang RF; Parkins M; Trapani JA; Harrison JJ; Mody CH
PLoS Pathog; 2022 Feb; 18(2):e1010325. PubMed ID: 35202434
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
[TBL] [Abstract][Full Text] [Related]
15. Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity.
Al Absi A; Wurzer H; Guerin C; Hoffmann C; Moreau F; Mao X; Brown-Clay J; Petrolli R; Casellas CP; Dieterle M; Thiery JP; Chouaib S; Berchem G; Janji B; Thomas C
Cancer Res; 2018 Oct; 78(19):5631-5643. PubMed ID: 30104240
[TBL] [Abstract][Full Text] [Related]
16. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms.
Selathurai A; Deswaerte V; Kanellakis P; Tipping P; Toh BH; Bobik A; Kyaw T
Cardiovasc Res; 2014 Apr; 102(1):128-37. PubMed ID: 24469537
[TBL] [Abstract][Full Text] [Related]
17. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.
Cao X; Cai SF; Fehniger TA; Song J; Collins LI; Piwnica-Worms DR; Ley TJ
Immunity; 2007 Oct; 27(4):635-46. PubMed ID: 17919943
[TBL] [Abstract][Full Text] [Related]
18. Vesicle-associated membrane protein 7 (VAMP-7) is essential for target cell killing in a natural killer cell line.
Marcet-Palacios M; Odemuyiwa SO; Coughlin JJ; Garofoli D; Ewen C; Davidson CE; Ghaffari M; Kane KP; Lacy P; Logan MR; Befus AD; Bleackley RC; Moqbel R
Biochem Biophys Res Commun; 2008 Feb; 366(3):617-23. PubMed ID: 18042464
[TBL] [Abstract][Full Text] [Related]
19. The 5' flanking region of the human granzyme H gene directs expression to T/natural killer cell progenitors and lymphokine-activated killer cells in transgenic mice.
MacIvor DM; Pham CT; Ley TJ
Blood; 1999 Feb; 93(3):963-73. PubMed ID: 9920846
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.
Swift BE; Williams BA; Kosaka Y; Wang XH; Medin JA; Viswanathan S; Martinez-Lopez J; Keating A
Haematologica; 2012 Jul; 97(7):1020-8. PubMed ID: 22271890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
